二、股东会现场会议参会股东或股东代理人应根据《大东方关于召开2025年第二次 临时股东会的通知》（本公司于2025年11月25日在上海证券交易所网站www.sse.com.cn 及上海证券报的公告）的要求，在2025年12月8日10:00—16:00期间，提供身份证明、股 票账户卡、授权委托书等资料向公司董事会办公室办理参会登记。 三、为保证股东会现场会议的严肃性和正常秩序，切实维护股东的合法权益，务必 请出席现场会议的股东或股东代理人按股东会会议通知的要求携带参会资格登记资料， 提前到达会场登记参会资格并签到。未能提供有效参会资格登记资料并办理签到的，不 得参加本次股东会现场会议。除出席本次会议的公司股东、董事、高级管理人员、公司 聘请的鉴证律师、相关工作人员以及董事会邀请的人员外，公司有权依法拒绝其他人员 进入会场。 四、股东或股东代理人参加本次股东会现场会议，依法享有发言权、质询权、表决 权等各项权利，同时须认真履行法定义务，不得侵犯其他股东的合法权益，不得扰乱会 议秩序。 五、股东或股东代理人如需发言，应提前进行登记，由主持人安排发言。股东提问 应举手示意，并按照会议主持人的安排进行。发言及提问前应先 ...

Core Viewpoint - The company, Da Dongfang, announced the transfer of an 80% stake in Jinhua Lianji Hospital and related debts to a biotechnology firm, indicating a strategic shift in its healthcare investments [1] Group 1: Company Actions - Da Dongfang's subsidiary, Shanghai Junyao Medical Health Technology Co., plans to transfer 80% of its stake in Jinhua Lianji Hospital to Jinhua Lin Tian Biotechnology Co. for 1 yuan [1] - The debts owed to Junyao Medical by Jinhua Lianji, totaling approximately 89.99 million yuan, will be transferred for 580,000 yuan [1] Group 2: Financial Overview - For the first half of 2025, Da Dongfang's revenue composition is as follows: medical services at 79.25%, department store retail at 14.91%, food and beverage sales at 5.7%, and other at 0.57%, with a negative offset of -0.44% [1] - As of the report, Da Dongfang's market capitalization stands at 4.4 billion yuan [1]

Economic Information - China's textile and apparel exports from January to October 2025 totaled $243.95 billion, a decrease of 1.6%. In October alone, exports were $22.26 billion, down 12.6% [2][6] - The Shanghai Cyberspace Administration has launched a special enforcement action to address the misuse of AI technologies, focusing on compliance to support the high-quality development of emerging industries. During this action, 54 apps utilizing generative AI technology were removed from local app stores [2][6] Company Alerts - ST Changyuan's chairman Qiao Wenjian has been detained for suspected job-related violations [4] - Saiwei Electronics' second-largest shareholder, the Big Fund, reduced its stake by 1.07% from September 23 to November 24 [4][6] - Yidian Tianxia's second-largest shareholder, Ningbo Zhongdianyi Enterprise Management Partnership, sold shares during a period of stock volatility [4][6] - Wireless Media's shareholders plan to reduce their holdings by up to 4.70% [4][6] - Huifa Foods' shareholder Hui Xiping intends to reduce his stake by up to 3% [4][6] - Dongfang Ocean's shareholder Guoyuan Fund plans to reduce its stake by up to 3% [4][6] - Other companies with shareholders planning to reduce stakes include Dinglong Co., Xinghui Entertainment, Zhongke Information, and others, with reductions ranging from 0.04% to 4.70% [4][6] Overseas Alerts - JPMorgan's commodity research head, Natasha Kaneva, indicated that without intervention, the global oil market will face a surplus of 2.8 million barrels per day next year, and 2.7 million barrels per day by 2027. Under these conditions, Brent crude oil prices could drop below $60 per barrel in 2026 and end the year at over $40 per barrel. By 2027, the average price may fall to $42 per barrel, potentially dropping to the $30 range by year-end [3][6] - German Chancellor Merz stated that the U.S. proposed peace plan for Ukraine is unlikely to be finalized by the 27th, with only small-scale progress expected in the coming days [2][3]

Group 1 - The core point of the article is that Dazhongfang (SH 600327) held a temporary board meeting on November 24, 2025, to discuss the proposal for transferring equity and debt of its controlling subsidiary [1] - For the first half of 2025, Dazhongfang's revenue composition was as follows: medical services accounted for 79.25%, department store retail for 14.91%, food and beverage sales for 5.7%, other for 0.57%, and offset for -0.44% [1] - As of the report, Dazhongfang's market capitalization was 4.4 billion yuan [1] Group 2 - Dapeng Industrial's strategic placement benefited its insiders, with a subscription price of 9 yuan, and the stock surged to 118 yuan on its first trading day, resulting in a paper profit of 24.92 million yuan for the actual controller and his brother [1]

Core Viewpoint - The company is divesting its 80% stake in Jinhua Lianji Hospital for 1 yuan and transferring its debt of approximately 89.99 million yuan for 5.8 million yuan to optimize its healthcare service business and improve asset structure [1][2]. Group 1: Transaction Details - The company’s subsidiary, Junyao Medical, will transfer its 80% stake in Jinhua Lianji Hospital to Jinhua Lintian Biotechnology Co., Ltd. for 1 yuan [1]. - The debt owed to Junyao Medical by Jinhua Lianji, amounting to approximately 89.99 million yuan, will be transferred for 580,000 yuan [1]. - Since its acquisition in March 2022, Jinhua Lianji Hospital has incurred cumulative losses of 79.15 million yuan [1]. Group 2: Financial Impact - The transaction is expected to reduce the company's consolidated net profit attributable to shareholders by 34.25 million yuan in 2025 [2]. - The company reported a total revenue of 2.645 billion yuan for the first three quarters of 2025, a year-on-year decrease of 4.23% [2]. - The net profit attributable to shareholders for the same period was 55.66 million yuan, down 33.12% year-on-year [2]. Group 3: Company Background - The company, founded in 1988, is a leading commercial retail service enterprise in Wuxi and became the first commercial retail company listed in Jiangsu Province in 2002 [2]. - It is a member of the Junyao Group and serves as the main entity for the modern consumption sector of the group [2]. - After the divestment of Jinhua Lianji, the company still holds assets in the healthcare sector, including Junyao Pediatrics and Yaan Health, but is currently focusing on cost reduction and strategic restructuring [2].

Core Viewpoint - The company, Da Dongfang, announced the transfer of 80% equity and debt claims of Jinhua Lianji Hospital to Jinhua Lin Tian Biotechnology Co., aiming to optimize its healthcare service business structure due to ongoing losses since acquisition [1] Group 1: Transaction Details - Shanghai Junyao Medical Health Technology Co., a subsidiary of Da Dongfang, plans to transfer 80% of its equity in Jinhua Lianji Hospital for 1 yuan [1] - The debt claims held by Junyao Medical against Jinhua Lianji amount to approximately 89.991 million yuan, which will be transferred for 5.8 million yuan [1] Group 2: Financial Performance - Since the acquisition in March 2022, Jinhua Lianji Hospital has incurred cumulative losses of 79.15 million yuan up to September 2025 [1] - The hospital has not reached a break-even point due to changes in the market environment and healthcare policies since 2022 [1] Group 3: Strategic Intent - The company aims to enhance service scale and operational efficiency through a professional management team and market-oriented operations [1] - The transfer of equity and debt is part of a strategy to optimize the asset structure and improve the quality and efficiency of the healthcare business segment [1]

本次交易完成后，将对2025年合并报表减少归属于母公司净利润3,425.05万元，减少归属于母公司的所 有者权益3,425.05万元。本次交易完成后，预计未来会消减该标的方持续亏损对公司的影响。本次交易 完成后，将优化公司医疗服务业务板块的整体资产质量，并提升该业务板块的综合经营效益。 大东方（600327）(600327.SH)发布公告，公司所属控股子公司上海均瑶医疗健康科技有限公司(简称"均 瑶医疗")拟将所持有的金华联济医院有限公司(简称"金华联济")80%的股权及均瑶医疗对金华联济的债 权转让给金华市林天生物科技有限公司(简称"林天生物")。其中：均瑶医疗持有的金华联济80%股权， 拟以1元转让给受让方;均瑶医疗享有的对金华联济的债权合计约8999.10万元，拟以580万元转让给受让 方。 ...

Core Viewpoint - The company, Da Dongfang, has a high rolling price-to-earnings (PE) ratio of 274.61, significantly above the industry average of 44.32, indicating potential overvaluation in the market [1][2]. Company Summary - Da Dongfang's closing price on November 24 was 4.99 yuan, reflecting a 2.25% increase, with a total market capitalization of 4.415 billion yuan [1]. - The company operates in the retail and healthcare sectors, focusing on department store retail, the Sanfengqiao brand, and healthcare services [1]. - For the third quarter of 2025, Da Dongfang reported a revenue of 2.645 billion yuan, a year-on-year decrease of 4.23%, and a net profit of 55.6589 million yuan, down 33.12% from the previous year, with a gross margin of 16.50% [1]. Industry Summary - The average PE ratio for the healthcare services industry is 44.32, with a median of 60.11, positioning Da Dongfang at the 38th rank within the industry [1][2]. - The industry shows a range of PE ratios, with notable companies like WuXi AppTec at 18.70 and Ai Er Eye Hospital at 33.46, indicating varying levels of valuation across the sector [2].

金华联济医院有限公司 审计报告 2025年1-9月 公证天业会计师事务所(特殊普通合伙) Gongzheng Tianye Certified Public Accountants, SGP 中国 . 江苏 . 无锡 Wuxi . Jiangsu . China 总机：86（510）68798988 Tel：86（510）68798988 传真：86（510）68567788 Fax：86（510）68567788 电子信箱：mail@gztycpa.cn E-mail：mail@gztycpa.cn 审计报告 苏公 W[2025]A1311 号 金华联济医院有限公司全体股东： 联济公司管理层（以下简称管理层）负责按照企业会计准则的规定编制财务报表， 第 1 页 共 3 页 使其实现公允反映，并设计、执行和维护必要的内部控制，以使财务报表不存在由于舞 弊或错误导致的重大错报。 一、审计意见 我们审计了金华联济医院有限公司（以下简称联济公司）财务报表，包括2025年9 月30日的资产负债表，2025年1-9月的利润表、现金流量表、所有者权益变动表以及相 关财务报表附注。 我们认为，后附的财务报表在所有重大方面按 ...

本报告依据中国资产评估准则编制 无锡商业大厦大东方股份有限公司 委托的上海均瑶医疗健康科技有限公司 拟进行股权转让涉及的金华联济医院有限公司 股东全部权益价值资产评估报告 沪申威评报字(2025) 第 1037 号 （共 1 册,第 1 册） 上海申威资产评估有限公司 2025年11月19日 上海申威资产评估有限公司 地址:上海市东体育会路 816 号 C 楼 电 话: 021-31273006 传 真: 021-31273013 邮编:200083 目 景 | 声 07 - | | --- | | 車 - 摘 | | F X | | 一、委托人、被评估单位和资产评估委托合同约定的其他评估报告使用人概况 3 | | 一、 淫佑目的 | | 三、评估对象和评估范围 | | 、价值类型及其定义 | | 五、评估基准日 | | 六、汪佑依据 | | 十、深仕方法 | | 儿、涿什程序实施过程和情况 | | 力、评估假设。… | | +、谣估结论 | | 评估结论详细情况见资产评估明细表 | | 十一、特别事项说明 ……………………………………………………………………………………………………………………………………… ...